Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Illumina Inc (ILMN)

Illumina Inc (ILMN)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Global Whole Genome and Exome Sequencing Market: Focus on Product, Workflow, Application, End User, Country Data (16 Countries), and Competitive Landscape - Analysis and Forecast, 2019-2029

, /PRNewswire/ --Read the full report: • Product – Kits, Instruments• Workflow – Sample Extraction/Purification, Library Preparation, Library Quantification, Analysis (Bioinformatics)• Application...

CGIX : 3.03 (+3.77%)
ERFSF : 665.0400 (+2.16%)
GE : 6.51 (-3.98%)
ILMN : 363.62 (-2.52%)
LH : 172.40 (-1.86%)
QGEN : 43.78 (+0.78%)
Ginkgo Bioworks to Build Infrastructure for Rapid Epidemic Response with $70MM Investment

, /PRNewswire/ -- Today, is announcing a $70MM investment from (Nasdaq: ILMN) and existing Ginkgo investors, General Atlantic and Viking Global Investors. This will enable Ginkgo to build the infrastructure...

ILMN : 363.62 (-2.52%)
The microfluidics market is projected to grow at a CAGR of 22.9%

, /PRNewswire/ -- The microfluidics market is projected to grow at a CAGR of 22.9%.The global microfluidics market size is projected to reach by 2025 from in 2020, at a CAGR of 22.9% during the forecast...

ABT : 91.25 (-0.92%)
A : 87.15 (+0.53%)
ILMN : 363.62 (-2.52%)
PKI : 99.45 (+0.15%)
VRTX vs. ILMN: Which Stock Should Value Investors Buy Now?

VRTX vs. ILMN: Which Stock Is the Better Value Option?

VRTX : 277.78 (+0.14%)
ILMN : 363.62 (-2.52%)
Watch for Illumina Inc to Potentially Pullback After Gaining 1.15% Yesterday

Illumina Inc (NASDAQ:ILMN) traded in a range yesterday that spanned from a low of $355.35 to a high of $361.86. Yesterday, the shares gained 1.1%, which took the trading range above the 3-day high of...

ILMN : 363.62 (-2.52%)
Amid the COVID-19 crisis and the looming economic recession, the Bioinformatics market worldwide will grow by a projected US$12.5 Billion, during the analysis period

, /PRNewswire/ --

A : 87.15 (+0.53%)
ILMN : 363.62 (-2.52%)
Here's Why You Should Hold on to Illumina (ILMN) Stock for Now

Investors continue to be optimistic about Illumina (ILMN) on its focus on partnerships and robust demand for its products.

ILMN : 363.62 (-2.52%)
OMI : 7.73 (-0.26%)
SRDX : 36.26 (-5.84%)
APHA : 4.18 (-3.02%)
Global Bioinformatics Industry Analysis, 2014-2024 Featuring Profiles of Leading Players Including Illumina, Life Technologies, Qiagen, Agilent Technologies, and PerkinElmer

, /PRNewswire/ -- The report has been added to offering.

A : 87.15 (+0.53%)
ILMN : 363.62 (-2.52%)
LIFE : 3.74 (+0.81%)
PKI : 99.45 (+0.15%)
Illumina, Inc. and the Illumina Corporate Foundation Commit $10 Million to COVID-19 Response and Research

Illumina, Inc. (NASDAQ: ILMN) is committed to supporting the global, national and local relief efforts of our customers, employees and communities, as we unite to combat COVID-19. Giving back is in our...

ILMN : 363.62 (-2.52%)
Natera and Illumina Settle Patent Dispute

and , /PRNewswire/ --  (NASDAQ: NTRA), a pioneer and global leader in cell-free DNA testing, and Illumina Inc. (NASDAQ: ILMN), a global leader in next-generation sequencing platforms, today announced...

NTRA : 42.82 (-1.43%)
ILMN : 363.62 (-2.52%)
Next-Generation Sequencing Market to Soar at 22.2% CAGR till 2026; Increasing Demand for Advanced Diagnostics for Chronic Diseases to Fuel the Market: Fortune Business Insights(TM)

The global next-generation sequencing market size is projected to touch USD 31,411.3 million by 2026, exhibiting a CAGR of 22.2% during the forecast period. Increasing prevalence of cancer worldwide is...

ERRFY : 16.7500 (+7.72%)
ILMN : 363.62 (-2.52%)
PKI : 99.45 (+0.15%)
The companion diagnostics industry analysis projects the market to grow at a significant CAGR of 12.45% during the forecast period, 2020-2030

, /PRNewswire/ -- Read the full report: • What are the long-term and short-term impacts of companion diagnostics on the human health continuum?• What are the major market drivers, challenges, and...

ABT : 91.25 (-0.92%)
A : 87.15 (+0.53%)
ICLR : 164.87 (-0.45%)
ILMN : 363.62 (-2.52%)
MYGN : 14.34 (-0.49%)
QGEN : 43.78 (+0.78%)
Watch for Illumina Inc to Potentially Pullback After Gaining 1.24% Yesterday

Illumina Inc (NASDAQ:ILMN) traded in a range yesterday that spanned from a low of $314.47 to a high of $320.00. Yesterday, the shares gained 1.2%, which took the trading range above the 3-day high of...

ILMN : 363.62 (-2.52%)
Illumina Inc Set to Possibly Pullback After Yesterday's Rally of 1.24%

Illumina Inc (NASDAQ:ILMN) traded in a range yesterday that spanned from a low of $314.47 to a high of $320.00. Yesterday, the shares gained 1.2%, which took the trading range above the 3-day high of...

ILMN : 363.62 (-2.52%)
Burning Rock deepens cooperation with Illumina to promote development and standardization of NGS-based cancer therapy selection in China

Burning Rock and Illumina (NASDAQ: ILMN), a global leader in gene sequencing and array-based technologies, jointly announced today that they are joining forces to promote the development and standardization...

ILMN : 363.62 (-2.52%)
GRAIL Announces $390 Million Series D Financing

GRAIL, Inc., a healthcare company whose mission is to detect cancer early, when it can be cured, today announced a $390 million Series D financing round. New investors including Public Sector Pension Investment...

ILMN : 363.62 (-2.52%)
GILD vs. ILMN: Which Stock Should Value Investors Buy Now?

GILD vs. ILMN: Which Stock Is the Better Value Option?

GILD : 75.01 (-0.41%)
ILMN : 363.62 (-2.52%)
Illumina Welcomes Alex Aravanis as Chief Technology Officer and Appoints Mostafa Ronaghi to Lead Entrepreneurial Development

Illumina (NASDAQ: ILMN) today announced the appointment of Alex Aravanis as Chief Technology Officer. Dr. Aravanis will be responsible for leading Illumina's research and technology development functions...

ILMN : 363.62 (-2.52%)
Illumina (ILMN) Beats Q1 Earnings Estimates, Withdraws View

Illumina (ILMN) exhibits robust growth in the first quarter of 2020 fueled by strong performance of the sequencing consumable subsegment despite the coronavirus pandemic.

BIIB : 300.91 (+0.14%)
ILMN : 363.62 (-2.52%)
LLY : 150.96 (+0.21%)
APHA : 4.18 (-3.02%)
Illumina (ILMN) Q1 Earnings and Revenues Top Estimates

Illumina (ILMN) delivered earnings and revenue surprises of 30.16% and 0.25%, respectively, for the quarter ended March 2020. Do the numbers hold clues to what lies ahead for the stock?

ILMN : 363.62 (-2.52%)

Van Meerten Stock Picks

My 5 Favorite Mid Caps
Summary 100% technical buy signals with current momentum.
CRUS +0.42 , SEDG +3.48 , THC -2.13 , TER +1.13 , LITE -0.77
Jim Van Meerten uses Barchart's tools to offer daily stock picks and recommendations. His portfolios have been honored by Marketocracy and Morningstar.

InsideFutures Commentary

InsideFutures is a twice weekly newsletter that features a selection of the latest and best commodities commentary appearing on Barchart.com. Delivered every Wednesday and Friday morning to your inbox.

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar